Dr. Joseph Yi, MD

NPI: 1861565285
Total Payments
$17,517
2024 Payments
$1,954
Companies
56
Transactions
1,053
Medicare Patients
4,115
Medicare Billing
$309,270

Payment Breakdown by Category

Food & Beverage$17,299 (98.8%)
Education$217.63 (1.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,299 1,042 98.8%
Education $217.63 11 1.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,336 119 $0 (2024)
Lilly USA, LLC $2,050 126 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,770 97 $0 (2024)
Novo Nordisk Inc $1,669 172 $0 (2024)
ABBVIE INC. $1,280 79 $0 (2024)
Amgen Inc. $1,039 62 $0 (2023)
PFIZER INC. $829.26 45 $0 (2024)
Astellas Pharma US Inc $674.58 36 $0 (2024)
Amarin Pharma Inc. $621.42 49 $0 (2021)
GlaxoSmithKline, LLC. $512.26 26 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,954 101 Lilly USA, LLC ($309.41)
2023 $2,594 135 Lilly USA, LLC ($324.64)
2022 $2,069 123 Novo Nordisk Inc ($298.53)
2021 $2,435 150 AbbVie Inc. ($472.58)
2020 $2,182 135 AstraZeneca Pharmaceuticals LP ($346.95)
2019 $2,438 140 AstraZeneca Pharmaceuticals LP ($585.56)
2018 $1,947 134 AstraZeneca Pharmaceuticals LP ($440.53)
2017 $1,897 135 AstraZeneca Pharmaceuticals LP ($298.02)

All Payment Transactions

1,053 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/09/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.00 General
Category: PSYCHIATRY
12/06/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $22.18 General
Category: Cardiovascular and Metabolism
12/03/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.55 General
Category: DIABETES
11/20/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $22.46 General
Category: VACCINE
11/15/2024 Kowa Pharmaceuticals America, Inc. ZORYVE (Drug) Food and Beverage In-kind items and services $14.02 General
Category: DERMATOLOGY
11/13/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $28.84 General
Category: Diabetes
11/12/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.98 General
Category: DIABETES
11/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $6.00 General
Category: DIABETES
11/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $23.57 General
Category: Respiratory
10/29/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $1.72 General
Category: Diabetes
10/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $5.09 General
Category: DIABETES
10/21/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $22.53 General
Category: Biological
10/17/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $25.36 General
Category: Cardio-renal
10/07/2024 Kowa Pharmaceuticals America, Inc. ZORYVE (Drug) Food and Beverage In-kind items and services $16.67 General
Category: DERMATOLOGY
10/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $4.75 General
Category: DIABETES
10/01/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $21.38 General
Category: Respiratory
09/30/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.03 General
Category: Diabetes
09/26/2024 Novo Nordisk Inc Rybelsus (Drug) Food and Beverage In-kind items and services $18.52 General
Category: Diabetes
09/24/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $25.81 General
Category: Diabetes
09/17/2024 Biogen, Inc. LEQEMBI (Drug) Food and Beverage In-kind items and services $21.04 General
Category: Neurology
09/17/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $15.04 General
Category: NEUROSCIENCE
09/13/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.84 General
Category: RESPIRATORY
09/11/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $24.78 General
Category: VACCINE
09/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $26.26 General
Category: DIABETES
09/10/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $24.49 General
Category: Diabetes Care

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,140 1,757 $156,833 $90,471
2022 12 1,032 1,509 $139,494 $81,130
2021 17 964 1,420 $124,005 $75,257
2020 19 979 1,571 $121,062 $62,412
Total Patients
4,115
Total Services
6,257
Medicare Billing
$309,270
Procedure Codes
60

All Medicare Procedures & Services

60 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 169 462 $48,510 $31,293 64.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 131 131 $39,300 $18,387 46.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 111 158 $24,806 $12,669 51.1%
99497 Advance care planning, first 30 minutes Office 2023 152 152 $18,240 $12,044 66.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 92 155 $10,075 $6,230 61.8%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 134 134 $4,020 $2,768 68.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 163 339 $2,750 $2,400 87.3%
G0008 Administration of influenza virus vaccine Office 2023 59 59 $2,358 $1,972 83.6%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2023 29 29 $1,450 $919.88 63.4%
96372 Injection of drug or substance under skin or into muscle Office 2023 33 68 $2,584 $766.99 29.7%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2023 30 30 $1,260 $613.41 48.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 37 40 $1,480 $407.73 27.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 150 273 $42,861 $25,084 58.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 144 291 $30,555 $19,093 62.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 110 110 $33,000 $15,875 48.1%
99497 Advance care planning, first 30 minutes Office 2022 90 90 $10,800 $7,552 69.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 51 82 $5,310 $3,642 68.6%
G0008 Administration of influenza virus vaccine Office 2022 78 79 $2,991 $2,605 87.1%
G0444 Annual depression screening, 15 minutes Office 2022 120 120 $3,600 $2,499 69.4%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2022 69 70 $3,500 $2,087 59.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 12 12 $2,856 $1,092 38.2%
36415 Insertion of needle into vein for collection of blood sample Office 2022 151 317 $1,590 $939.18 59.1%
96372 Injection of drug or substance under skin or into muscle Office 2022 31 38 $1,432 $382.91 26.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 26 27 $999.00 $278.49 27.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 138 251 $39,407 $22,997 58.4%

About Dr. Joseph Yi, MD

Dr. Joseph Yi, MD is a Family Medicine healthcare provider based in Buena Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861565285.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Yi, MD has received a total of $17,517 in payments from pharmaceutical and medical device companies, with $1,954 received in 2024. These payments were reported across 1,053 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($17,299).

As a Medicare-enrolled provider, Yi has provided services to 4,115 Medicare beneficiaries, totaling 6,257 services with total Medicare billing of $309,270. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Buena Park, CA
  • Active Since 11/15/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1861565285

Products in Payments

  • FARXIGA (Drug) $1,791
  • JARDIANCE (Drug) $1,554
  • Ozempic (Drug) $814.82
  • MOUNJARO (Drug) $640.33
  • EVENITY (Biological) $631.24
  • Vascepa (Drug) $621.42
  • LINZESS (Drug) $518.94
  • TRULICITY (Drug) $506.64
  • Rybelsus (Drug) $373.38
  • ENTRESTO (Drug) $350.93
  • TRADJENTA (Drug) $336.38
  • Creon (Drug) $333.47
  • BREZTRI (Drug) $289.64
  • Kerendia (Drug) $273.06
  • Tymlos (Biological) $262.93
  • EMGALITY (Drug) $253.34
  • Korlym (Drug) $241.30
  • MYRBETRIQ (Drug) $240.79
  • TRELEGY ELLIPTA (Drug) $229.15
  • Amitiza (Drug) $224.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Buena Park